Reactive acyl glucuronides: Possible role in small intestinal toxicity induced by nonsteroidal anti-inflammatory drugs

Toxic Substance Mechanisms

Volumn 18, Issue 2, 1999, Pages 83-100

  Boelsterli, Urs A ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

BACTERIAL FLORA; ENTEROHEPATIC CIRCULATION; GASTROINTESTINAL MUCOSA; GLUCURONIDATION; INTESTINE FLORA; INTESTINE INJURY; LIVER METABOLISM; MEDIATOR RELEASE; PROSTAGLANDIN SYNTHESIS; REVIEW; RHEUMATIC DISEASE; SMALL INTESTINE MUCOSA; TOXICITY TESTING;

EID: 0032939053     PISSN: 10769188     EISSN: None     Source Type: Journal    
DOI: 10.1080/107691899229160     Document Type: Review

References (116)

1. 13C-labeling and nuclear magnetic resonance spectroscopy. J. Pharmacol. Toxicol. Meth. 37:237-243.
2. Allison, M., Howatson, A., Torrance, C., Lee, F., and Russell, R. 1992. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 327:749-754.
3. Anthony, A., Sim, R., Dhillon, A. P., Pounder, R. E., and Wakefield, A. J. 1996. Gastric mucosal contraction and vascular injury induced by indomethacin precede neutrophil infiltration in the rat. Gut 39:363-368.
4. Appleyard, C. B., McCafferty, D. M. M., Tigley, A. W., Swain, M. G., and Wallace, J. L. 1996. Tumor necrosis factor mediation of NSAID-induced gastric damage - role of leukocyte adherence. Am. J. Physiol. (Gastrointest. Liver Physiol.) 33:G42-G48.
5. Atchison, C. R., Hargus, S. J., Daiker, D., Aronson, J., West, B., and Moslen, M. T. 1997. Histopathology and diclofenac protein adducts in rat liver and intestine. Fund. Appl. Toxicol. (suppl.) 36:211 (abstract).
6. Bailey, M. J., and Dickinson, R. G. 1996. Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma. Chem. Res. Toxicol. 9:659-666.
7. Batt, A. M., Magdalou, J., Vincentviry, M., Ouzzine, M., Fourneligleux, S., Galteau, M. M., and Siest, G. 1994. Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltransferases. Clin. Chim. Acta 226:171-190.
8. Beck, W. S., Schneider, H. T., Dietzel, K., Nuernberg, B., and Brune, K. 1990. Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Arch. Toxicol. 64:210-217.
9. Benet, L. Z., Spahn-Langguth, H., Iwakawa, S., Volland, C., Mizuma, T., Mayer, S., Mutschler, E., and Lin, E. T. 1993. Predictability of the covalent binding of acidic drugs in man. Life Sci. 53:PL141-PL146.
10. Bjarnason, I., Hayllar, J., Macpherson, A., and Russell, A. 1993. Side effects of nonsteroidal antiinflammatory drugs on the small and large intestine in humans. Gastroenterology 104:1832-1847.
11. Blower, P. R. 1992. The unique pharmacologic profile of nabumetone. J. Rheumatol. 19 (suppl. 36):13-19.
12. Boelsterli, U. A., Zimmerman, H. J., and Kretz-Rommel, A. 1995. Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: Molecular mechanisms and pathology. Crit. Rev. Toxicol. 25:207-235.
13. Brune, K. 1990. Is there a rational basis for the different spectra of adverse effects of nonsteroidal anti-inflammatory drugs (NSAIDs)? Drugs 40 (suppl. 5):12-15.
14. Brune, K., and Beck, W. S. 1991. Towards safer nonsteroidal anti-inflammatory drugs. Agents Actions 32 (suppl.):13-25.
15. Brune, K., Dietzel, K., Nürnberg, B., and Schneider, H. T. 1987. Recent insight into the mechanism of gastrointestinal tract ulceration. Eur. J. Rheumatol. Inflamm. 9:8-14.
16. Burchell, B., Brierley, C. H., and Rance, D. 1995. Specificity of human UDP-glucuronosyltransferases and xenobiotic glucuronidation. Life Sci. 57:1819-1831.
17. Castillo, M., and Smith, P. C. 1995. Disposition and reactivity of ibuprofen and ibufenac acyl glucuronides in vivo in the Rhesus monkey and in vitro with human serum albumin. Drug Metab. Dispos. 23:566-572.
18. Castillo, M., Lam, Y. W. F., Dooley, M. Y., Stahl, E., and Smith, P. C. 1995. Disposition and covalent binding of ibuprofen and its acyl glucuronide in the elderly. Clin. Pharmacol. 57:636-644.
19. Chmaisse, H. M., Antoon, J. S., Kvietys, P. R., Grisham, M. B., and Perry, M. A. 1994. Role of leukocytes in indomethacin-induced small bowel injury in the rat. Am. J. Physiol. (Gastrointest. Liver Physiol.) 266:G239-G246.
20. Coffman, B. L., King, C. D., Rios, G. R., and Tephly, T. R. 1998. The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab. Dispos. 26:73-77.
21. Cohen, S. D., and Khairallah, E. A. 1997. Selective protein arylation and acetaminophen-induced hepatotoxicity. Drug Metab. Rev. 29:59-77.
22. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., and Deeley, R. G. 1992. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258:1650-1654.
23. Collins, A., Reid, J., Soper, C., and Notarianni, L. 1995. Characteristics of ulcers of the small bowel induced by nonsteroidal anti-inflammatory drugs in the rat: implications for clinical practice. Br. J. Rhematol. 34:727-731.
24. Davies, N. M., and Anderson, K. E. 1997. Clinical pharmacokinetics of diclofenac: therapeutic insights and pitfalls. Clin. Pharmacokinet. 33:184-213.
25. Del Soldato, P., and Meli, A. 1978. Studies on the mechanism of fat-free diet (FFD) protection against indomethacin-induced intestinal ulcers. Proc. Soc. Exp. Biol. Med. 158:19-22.
26. Del Soldato, P., Foschi, D., Benoni, G., and Scarpignato, C. 1986. Oxygen free radicals interact with indomethacin to cause gastrointestinal injury. Agents Actions 17:484-488.
27. Dickinson, R. G. 1993. Acyl glucuronide conjugates: reactive metabolites of non-steroidal antiinflammatory drugs. Proc. West. Pharmacol. Soc. 36:157-162.
28. Dickinson, R. G., and King, A. R. 1991. Studies on the reactivity of acyl glucuronides - II. Interaction of diflunisal acyl glucuronide and its isomers with human serum albumin in vitro. Biochem. Pharmacol. 42:2301-2306.
29. Dickinson, R. G., and King, A. R. 1993. Studies on the reactivity of acyl glucuronides - V. Glucuronide-derived covalent binding of diflunisal to bladder tissue of rats and its modulation by urinary pH and beta-glucuronidase. Biochem. Pharmacol. 46:1175-1182.
30. Ding, A., Ojingwa, J. C., McDonagh, A. F., Burlingame, A. L., and Benet, L. Z. 1993. Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 90:3797-3801.
31. Ding, A., Zia-Amirhosseini, P., McDonagh, A. F., Burlingame, A. L., and Benet, L. Z. 1995. Reactivity of tolmetin glucuronide with human serum albumin. Identification of binding sites and mechanisms of reaction by tandem mass spectrometry. Drug Metab. Dispos. 23:369-376.
32. Duggan, D. E., Hooke, K. F., Noll, R. M., and Kwan, K C. 1975. Enterohepatic circulation of indomethacin and its role in intestinal irritation. Biochem. Pharmacol. 25:1749-1754.
33. Faed, E. M. 1984. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab. Rev. 15:1213-1249.
34. Freneaux, E., Fromenty, B., Berson, A., Labbe, G., Degott, C., Lettéron, P., Larrey, D., and Pessayre, D. 1990. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial β-oxidation of fatty acids. J. Pharmacol. Exp. Ther. 255:529-535.
35. Gillette, J. R. 1986. Significance of covalent binding of chemically reactive metabolites of foreign compounds to proteins and lipids. In Biological Reactive Intermediates III. Mechanisms of Action in Animal Models and Human Disease, eds. J. J. Kocsis, D. J. Jollow, C. M. Witmer, J. O. Nelson, and R. Snyder, pp. 63-82. New York: Plenum Press.
36. Hargus, S. J., Amouzedeh, H. R., Pumford, N. R., Myers, T. G., McCoy, S. C., and Pohl, L. R. 1994. Metabolic activation and immunochemical localization of liver protein adducts of the non-steroidal anti-inflammatory drug diclofenac. Chem. Res. Toxicol. 7:575-582.
37. Hargus, S. J., Martin, B. M., George, J. W., and Pohl, L. R. 1995. Covalent modification of rat liver dipeptidyl peptidase IV (CD26) by the nonsteroidal antiinflammatory drug diclofenac. Chem. Res. Toxicol. 8:993-996.
38. Illing, H. P. A. 1981. Techniques for microflora and associated metabolic studies in relation to the absorption and enterohepatic circulation of drugs. Xenobiotica 11:815-830.
39. Kent, T. H., Cardelli, R. M., and Stemler, F. W. 1969. Small intestinal ulcers and intestinal flora in rats given indomethacin. Am. J. Pathol. 54:237-248.
40. Keppler, D., and König, J. 1997. Expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J. 11:509-516.
41. King, A. R., and Dickinson, R. G. 1993. Studies on the reactivity of acyl glucuronides - IV. Covalent binding of diflunisal to tissues of the rat. Biochem. Pharmacol. 45:1043-1047.
42. Klaassen, C. D., and Watkins, J. B. 1984. Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacol. Rev. 36:1-67.
43. Klein, T., Nusing, R. M., Pfeilschifter, J., and Ullrich, V. 1994. Selective inhibition of cyclooxygenase 2. Biochem. Pharmacol. 48:1605-1610.
44. Kretz-Rommel, A., and Boelsterli, U. 1993. Diclofenac covalent protein binding is dependent on acyl glucuronide formation and is inversely related to acute cell injury in cultured rat hepatocytes. Toxicol. Appl. Pharmacol. 120:155-161.
45. Kretz-Rommel, A., and Boelsterli, U. A. 1994a. Mechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins. Retention of the glucuronic acid moiety in the adduct. Drug Metab. Disp. 22:956-961.
46. Kretz-Rommel, A., and Boelsterli, U. A. 1994b. Selective protein adducts to membrane proteins in cultured rat hepatocytes exposed to diclofenac. Radiochemical and immunochemical analysis. Mol. Pharmacol. 45:237-244.
47. Kretz-Rommel, A., and Boelsterli, U. A. 1995. Cytotoxic activity of T cells and non-T cells from diclofenac-immunized mice against cultured syngeneic hepatocytes exposed to diclofenac. Hepatology 22:213-222.
48. Kunkel, S. L., Spengler, M., May, M. A., Spengler, R., Larrick, J., and Remick, D. 1988. Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. J. Biol. Chem. 263: 5380-5384.
49. Langman, M. J. S., Morgan, L., and Worrall, A. 1985. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br. Med. J. 290:347-349.
50. Le, H. T., and Franklin, M. R. 1997. Selective induction of phase II drug metabolizing enzyme activities by quinolines and isoquinolines. Chem. Biol. Interact. 103:167-178.
51. Lichtenstein, D. R., Syngal, S., and Wolfe, M. M. 1995. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. The double-edged sword. Arthritis Rheumat. 38:5-18.
52. Lugea, A., Antolin, M., Mourelle, M., Guarner, F., and Malagelada, J. R. 1997. Deranged hydrophobic barrier of the rat gastroduodenal mucosa after parenteral nonsteroidal anti-inflammatory drugs. Gastroenterology 112:1931-1939.
53. Madon, J., Eckhardt, U., Gerloff, T., Stieger, B., and Meier, P. J. 1997. Functional expression of the rat liver canalicular isoform of the multidrug resistance-associated protein. FEBS Lett. 406:75-78.
54. Mahmud, T., Scott, D. L., and Bjarnason, I. 1996. A unifying hypothesis for the mechanism of NSAID-related gastrointestinal toxicity. Ann. Rheum. Dis. 55:211-213.
55. Mahmud, T., Wrigglesworth, J. M., Rafi, S., Scott, D. L., and Bjarnason, I. 1995. Uncoupling of oxydative phosphorylation by non-steroidal anti-inflammatory drugs (NSAIDs) is related to ionizable moiety and can be altered by modification of carboxylic group. Arthritis Rheumatol. 38 (suppl.):S207.
56. Mayer, R., Kartenbeck, J., Büchler, M., Jedlitschky, G., Leier, I., and Keppler, D. 1995. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. J. Cell Biol. 131:137-150.
57. McGurk, K. A., Remmel, R. P., Hosagrahara, V. P., Tosh, D., and Burchell, B. 1996. Reactivity of mefenamic acid 1-O-acyl glucuronide with proteins in vitro and ex vivo. Drug Metab. Dispos. 24:842-849.
58. McKinnon, G. E., and Dickinson, R. G. 1989. Covalent binding of diflunisal and probenecid to plasma protein in humans: Persistence of the adducts in the circulation. Res. Comm. Chem. Pathol. Pharmacol. 66:339-354.
59. Melarange, R., Gentry, C., O'Connell, C., Blower, P. R., Neil, C., Kelvin, A. S., and Toseland, C. D. 1992. Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-nathylacetic acid (6MNA). Comparative studies with indomethacin. Dig. Dis. Sci. 37:1847-1852.
60. Miura, S., Suematsu, M., Tanaka, S., Nagata, H., Houzawa, S., Suzuki, M., Kurose, I., Serizawa, H., and Tsuchiya, M. 1991. Microcirculatory disturbance in indomethacin-induced intestinal ulcer. Am. J. Physiol 261:G213-G219.
61. Müller, M., Roelofsen, H., and Jansen, P. L. M. 1996. Secretion of organic anions by hepatocytes: Involvement of homologues of the multidrug resistance protein. Semin. Liver Dis. 16:211-220.
62. Nygard, G. A., Anthony, A., Piasecki, C., Trevethick, M. A., Hudson, M., Dhillon, A. P., Pounder, R. E., and Wakefield, A. J. 1994. Acute indomethacin-induced jejunal injury in the rat: early morphological and biochemical changes. Gastroenterology 106:567-575.
63. O'Brien, W. M., and Bagby, G. F. 1985. Rare adverse reactions to nonsteroidal antiinflammatory drugs. J. Rheumatol. 12:562-567.
64. 4 and platelet-activating factor. J. Immunol. 147:3842-3847.
65. Oude Elferink, R. P. J., Meijer, D. K. F., Kuipers, F., Jansen, P. L. M., Groen, A. K., and Groothuis, G. M. M. 1995. Hepatobiliary secretion of organic compounds; molecular mechanisms of mebrane transport. Biochim. Biophys. Acta. (Rev. Biomembr.) 1241:215-268.
66. Pairet, M., and Engelhardt, G. 1996. Distinct isoforms (COX-1 and COX-2) of cyclooxygenases: possible physiological and therapeutic implications. Fundam. Clin. Pharmacol. 10:1-15.
67. Paulusma, C. C., Bosma, P. J., Zaman, G. J. R., Bakker, C. T. M., Otter, M., Scheffer, G. L., Scheper, R. J., Borst, P., and Oude Elferink, R. P. J. 1996. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271:1126-1128.
68. Priymenko, N., Gamier, F., Ferre, J. P., Delateur, P., and Toutain, P. L. 1998. Enantioselectivity of the enterohepatic recycling of carprofen in the dog. Drug Metab. Dispos. 26:170-176.
69. Pumford, N. R., Myers, T. G., Davila, J. C., Highet, R. J., and Pohl, L. R. 1993. Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac. Chem. Res. Toxicol. 6:147-150.
70. Reuter, B. K., Cirino, G., and Wallace, J. L. 1994. Markedly reduced intestinal toxicity of a diclofenac derivative. Life Sci. 55:PL1-PL8.
71. Reuter, B. K, Davies, N. M., and Wallace, J. L. 1997. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation. Gastroenterology 112:109-117.
72. Robert, A., and Asano, T. 1977. Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins 14:333-341.
73. Sallustio, B. C., Harkin, L. A., Mann, M. C., Krivickas, S. J., and Burcham, P. C. 1997. Genotoxicity of acyl glucuronide metabolites formed from clofibric acid and gemfibrozil: a novel role for phase-II-mediated bioactivation in the hepatocarcinogenicity of the parent aglycones? Toxicol. Appl. Pharmacol. 147:459-164.
74. Santucci, L., Fiorucci, S., DiMatteo, F. M., and Morelli, A. 1995. Role of tumor necrosis factor alpha release and leukocyte margination in indomethacin-induced gastric injury in rats. Gastroenterology 108:393-401.
75. Santucci, L., Fiorucci, S., Giansanti, M., Brunori, P. M., DiMatteo, F. M., and Morelli, A. 1994. Pentoxifylline prevents indomethacin induced acute gastric mucosal damage in rats: role of tumour necrosis factor alpha. Gut 35:909-915.
76. Scales, W. E., Chensue, S. W., Otterness, I., and Kunkel, S. L. 1989. Regulation of monokine gene expression: Prostaglandin E2 suppresses tumor necrosis factor but not interleukin 1α or β mRNA and cell associated bioactivity. J. Leukocyte Biol. 45:416-421.
77. Schneider, H. T., Nuernberg, B., Dietzel, K., and Brune, K. 1990. Biliary elimination of nonsteroidal anti-inflammatory drugs in patients. Br. J. Clin. Pharmacol. 29:127-131.
78. Seitz, S., and Boelsterli, U. A. 1998. Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats. Gastroenterology 775:1476-1482.
79. Seitz, S., Kretz-Rommel, A., Oude Elferink, R. P. J., and Boelsterli, U. A. 1998. Selective protein adduct formation of diclofenac glucuronide is critically dependent on the rat canalicular conjugate export pump (Mrp2). Chem. Res. Toxicol. 11:513-519.
80. Shack, M. E. 1966. Drug induced ulceration and perforation of the small bowel. Ariz. Med. 23:517-523.
81. Singh, G., Ramey, D. R., Morfeld, D., and Fries, J. F. 1994. Comparative toxicity of non-steroidal anti-inflammatory agents. Pharmacol. Ther. 62:175-191.
82. Smith, P. C., and Liu, J. H. 1995. Covalent binding of suprofen to renal tissue of rat correlates with excretion of its acyl glucuronide. Xenobiotica 25:531-540.
83. Smith, P. C., Benet, L. Z., and McDonagh, A. F. 1990. Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism. Drug Metab. Disp. 18:639-644.
84. Somasundaram, S., Rafi, S., Hayllar, J., Sighthorsson, G., Jacob, M., Price, A. B., Macpherson, A., Mahmod, T., Scott, D., Wrigglesworth, J. M., and Bjarnason, I. 1997. Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Gut 41:344-353.
85. Spahn-Langguth, H., and Benet, L. Z. 1992. Acyl glucuronides revisited - is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metab. Rev. 24:5-48.
86. Spatafora, M., Chiappara, G., D'Amico, D., Volpes, D., Melis, M., Pace, E., and Merendino, A. 1991. Effect of indomethacin on the kinetics of tumour necrosis factor alpha release and tumour necrosis factor alpha gene expression by human blood monocytes. Pharmacol. Res. 23:247-257.
87. Stewart, T. H. M., Hetenyi, C., Rowsell, H., and Orizaga, M. 1980. Ulcerative enterocolitis in dogs induced by drugs. J. Pathol. 131:363-378.
88. Sturges, H. F., and Krone, C. L. 1973. Ulceration and stricture of the jejunum in a patient on long-term indomethacin therapy. Am. J. Gastroenterol. 59:162-169.
89. Tabata, K., Yamaoko, K., Fukuyama, T., and Nakagawa, T. 1995. Evaluation of intestinal absorption into the portal system in enterohepatic circulation by measuring the difference in portal-venous blood concentrations. Pharmacol. Res. 12:880-883.
90. Trevethick, M. A., Bahl, A. K., Clayton, N. M., Strong, P., Sanjar, S., and Harman, I. W. 1994. Neutrophil infiltration does not contribute to the ulcerogenic effects of indomethacin in the rat gastric antrum. Agents Actions 43:39-43.
91. Uejima, M., Kinouchi, T., Kataoka, K., Hiraoka, I., and Ohnishi, Y. 1996. Role of intestinal bacteria in ileal ulcer formation in rats treated with a nonsteroidal antiinflammatory drug. Microbiol. Immunol. 40:553-560.
92. Van Breemen, R. B., and Fenselau, C. 1985. Acylation of albumin by 1-O-acyl glucuronides. Drug Metab. Disp. 13:318-320.
93. Vargas, M., and Franklin, M. R. 1997. Intestinal UDP-glucuronosyltransferase activities in rat and rabbit. Xenobiotica 27:413-421.
94. Venturatos, S. G., Hines, C., and Blalock, J. B. 1984. Ulceration of the small intestine in a patient with celiac disease. South. Med. J. 77:520-522.
95. Wade, L. T., Kenna, J. G., and Caldwell, J. 1997. Immunochemical identification of mouse hepatic protein adducts derived from the nonsteroidal anti-inflammatory drugs diclofenac, sulindac, and ibuprofen. Chem. Res. Toxicol. 10:546-555.
96. Wallace, J. L. 1997. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 112:1000-1016.
97. Wallace, J. L., and Chin, B. C. 1997. Inflammatory mediators in gastrointestinal defense and injury. Proc. Soc. Exp. Biol. Med. 214:192-203.
98. Wallace, J. L., Elliott, S. N., Del Soldato, P., McKnight, W., Sannicolo, F., and Cirino, G. 1997. Gastrointestinal-sparing anti-inflammatory drugs: the development of nitric oxide-releasing NSAIDs. Drug Develop. Res. 42:144-149.
99. Wallace, J. L., Reuter, B. K., and Cirino, G. 1994. Nitric oxide-releasing non-steroidal anti-inflammatory drugs: a novel approach for reducing gastrointestinal toxicity. J. Gastroenterol. Hepatol. 9:S40-S44.
100. Wallace, J. L., Reuter, B., Cicala, C., McKnight, W., Grisham, M. B., and Cirino, G. 1994a. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology 107:173-179.
101. Wallace, J. L., Reuter, B., Cicala, C., McKnight, W., Grisham, M., and Cirino, G. 1994b. A diclofenac derivative without ulcerogenic properties. Eur. J. Pharmacol. 257:249-255.
102. Walt, R., Katschinski, B., Logan, R., Ashley, J., and Langman, M. 1986. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1:489-492.
103. Wang, M., and Dickinson, R. G. 1998. Disposition and covalent binding of diflunisal and diflunisal acyl glucuronide in the isolated perfused rat liver. Drug Metab. Dispos. 26:98-104.
104. Wang, M., and Dickinson, R. G. 1998. Hepatobiliary transport of diflunisal conjugates and taurocholate by the perfused rat liver: the effect of chronic exposure of rats to diflunisal. Life Sci. 62:751-762.
105. Ware, J. A., Graf, M. L. M., Martin, B. M., Lustberg, L. R., and Pohl, L. R. 1998. Immunochemical detection and identification of protein adducts of diclofenac in the small intestine of rats: possible role in allergic reactions. Chem. Res. Toxicol. 11:164-171.
106. Wax, J., Clinger, W. A., Varner, P., Bass, P., and Winder, C. V. 1970. Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid. Gastroenterology 58:772-780.
107. Whitehouse, M. W. 1964. Biochemical properties of anti-inflammatory drugs - III. Uncoupling of oxidative phosphorylation in a connective tissue (cartilage) and liver mitochondria by salicylate analogues: relationship of structure to activity. Biochem. Pharmacol. 13:319-336.
108. Whittle, B. J. R. 1981. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 80:94-98.
109. Wijnholds, J., Evers, R., van Leusden, M. R., Mol, C. A. A. M., Zaman, G. J. R., Mayer, U., Beijnen, J. H., van der Valk, M., Krimpenfort, P., and Borst, P. 1997. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nature Med. 3:1275-1279.
110. Williams, A. M., and Dickinson, R. G. 1994. Studies on the reactivity of acyl glucuronides - VI. Modulation of reversible and covalent interaction of diflunisal acyl glucuronide and its isomers with human plasma protein in vitro. Biochem. Pharmacol. 47:457-467.
111. Williams, A. M., Worrall, S., De Jersey, J., and Dickinson, R. G. 1994. Studies on the reactivity of acyl glucuronides - VIII. Generation of an antiserum for the detection of diflunisal-modified proteins in diflunisal-doses rats. Biochem. Pharmacol. 49:209-217.
112. Wynne, H. A., Long, A., Nicholson, E., Ward, A., and Keir, D. 1998. Are altered pharmacokinetics of non-steroidal anti-inflammatory drugs (NSAIDs) a risk factor for gastrointestinal bleeding? Br. J. Clin. Pharmacol. 45:405-408.
113. Yamada, T., Deitch, E., Specian, R. D., Perry, M. A., Sartor, R. B., and Grisham, M. B. 1993. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 17:641-662.
114. Yesair, D. W., Callahan, M., Remington, L., and Kensler, C. J. 1970. Role of enterohepatic cycle of indomethacin on its metabolism, distribution in tissues and its excretion by rats, dogs and monkeys. Biochem. Pharmacol. 19:1579-1590.
115. Zahavi, I., Fisher, S., Marcus, H., Heckelman, B., Kiro, A., and Dinari, G. 1995. Oxygen radical scavengers are protective against indomethacin-induced intestinal ulceration in the rat. J. Ped. Gastroenterol. Nutr. 21:154-157.
116. Zia-Amirhosseini, P., Ojingwa, J. C., Spahn-Langguth, H., McDonagh, A. F., and Benet, L. Z. 1994. Enhanced covalent binding of tolmetin to proteins in humans after multiple dosing. Clin. Pharmacol. Ther. 55:21-27.